Factors such as existing medical conditions, potential drug interactions, and overall treatment goals need to be carefully evaluated
Int J Exerc Sci 11(2):404 Chee C, Shannon CE, Burns A, Selby AL, Wilkinson D, Smith K, Greenhaff PL, Stephens FB (2021) Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise
The dual receptor activity distinguishes tirzepatide from single GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or dulaglutide (Trulicity)
The results of the phase 3 clinical trial showed that participants lost an average of 15.3 kg in weight
states since 2017, with generally good customer ratings